Biohaven downgraded at RBC Capital Markets after SK Biopharma deal

Story context

What to watch: BHVN (BHVN) was downgraded by an analyst — check whether the thesis change is fundamental or just a valuation call.

Latest session change: $BHVN -6.12%

Tone and severity are deterministic keyword classification — not a prediction, a member vote, or a recommendation. Figures come from the published headline or preview. Session moves may include other news and do not establish cause.